[1]符雨嫣 何达 罗雅双 汪茹 王海银.可穿戴医疗设备的卫生技术评估方法学研究[J].中国卫生质量管理,2024,31(10):86-90.[doi:10.13912/j.cnki.chqm.2024.31.10.16]
 FU Yuyan,HE Da,LUO Yashuang.Research on Health Technology Assessment Methodology of Wearable Medical Devices[J].Chinese Health Quality Management,2024,31(10):86-90.[doi:10.13912/j.cnki.chqm.2024.31.10.16]
点击复制

可穿戴医疗设备的卫生技术评估方法学研究

参考文献/References:

[1]国家药品监督管理局.关于政协十三届全国委员会第三次会议第1219号(医疗体育类139号)提案答复的函:国药监提函〔2020〕34号[EB/OL].(2020-11-18)[2024-01-25].https://www.nmpa.gov.cn/zwgk/jyta/zhxta/202011180957251 88.html.[2]石用伍.可穿戴医疗设备的研究进展[J].医疗装备,2018,31(5):193-195.[3]魏奕星,邓朝华.可穿戴医疗设备在医疗健康领域的应用综述[J].中国数字医学,2019,14(12):22-25.[4]LU L, ZHANG J, XIE Y, et al. Wearable health devices in health care: narrative systematic review[J]. JMIR mHealth and uHealth, 2020, 8(11):e18907.[5]谷元静,史婷奇.可穿戴设备在医学领域中的研究进展[J].全科护理,2021,19(35):4954-4958.[6]颜 延,邹 浩,周 林,等.可穿戴技术的发展[J].中国生物医学工程学报,2015,34(6):644-653.[7]王海银,孙 辉,王昊德,等.价值重塑下的我国卫生技术评估发展与展望[J].中国卫生质量管理,2022,29(6):1-3,8.[8]孙 辉,金春林,刘 昕,等.高值医用耗材价值评估框架研究[J].中国卫生质量管理,2022,29(6):9-12.[9]蒋 硕,张 克,陈一依,等.可穿戴康复助行机器人安全性有效性评价要点分析[J]. 中国医疗器械杂志,2023,47(2):207-210. [10]王晓青,孟殿怀,赵 磊,等.可穿戴设备uCare在脑卒中患者社区康复中的应用效果[J].中国康复医学杂志,2019,34(10):1188-1192.[11]常 红,李佩佩,田思颖,等.可佩戴设备快速测量脑卒中患者血糖的准确性研究[J].中国护理管理,2022,22(3):339-343.[12]卢 雯,贾瑞笑,张星宇,等.可穿戴设备在膝关节置换术后患者康复中应用效果的Meta分析[J].中国医学装备,2023,20(12):55-61.[13]石泽亚,彭 希,陈华丽,等.可穿戴设备在心血管疾病患者主动健康管理中的应用与挑战[J].实用休克杂志(中英文),2023,7(1):35-38,43.[14]吴嘉慧,张筑欣,王建旗,等.贴式可穿戴动态心电记录分析系统对心律失常检测的有效性和安全性研究[J].中国循证心血管医学杂志, 2021, 13(6):1674-4055.[15]梅小丽,黄雨晨,周 健,等.无线可穿戴设备连续监测胸腔镜肺癌切除术后患者基本生命体征的前瞻性自身对照研究[J].中国胸心血管外科临床杂志,2024,31(2):229-235.[16]郭卫婷,刘建萍,张晓雪,等. 远程心脏康复有效性及依从性的系统评价再评价[J]. 中华护理杂志,2023,58(4):426-433.[17]尤炎丽,赵杰刚,张 弓,等.基于可穿戴设备监测的经皮冠状动脉介入治疗术后患者心脏康复运动指导模式的效果评价[J].中国康复医学杂志, 2020, 35(4):1001-1242.[18]YANG C, SHANG L, YAO S, et al. Cost, time savings and effectiveness of wearable devices for remote monitoring of patient rehabilitation after total knee arthroplasty: study protocol for a randomized controlled trial[J]. J Orthop Surg Res, 2023, 18(1):461-469.[19]JIA Y, WANG W, WEN D, et al. Perceived user preferences and usability evaluation of mainstream wearable devices for health monitoring[J]. Peer J, 2018, 25(6):e5350.[20]FENG Y, WU Y, LIU H, et al. Effect of the telemedicine-supported multicomponent exercise therapy in patients with knee osteoarthritis: study protocol for a randomized controlled trial[J]. Trials, 2023, 24(1):729-744.[21]JIANG X, MING WK, YOU JHS. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China[J]. J Cardiovasc Electrophysiol, 2019, 30(11):2387-2396.[22]AHMED A, AZIZ S, ABD-ALRAZAQ A, et al. The effectiveness of wearable devices using artificial intelligence for blood glucose level forecasting or prediction: systematic review[J]. J Med Internet Res, 2023, 25 (14):e40259.[23]ABD-ALRAZAQ A, ALSAAD R, HARFOUCHE M, et al. Wearable artificial intelligence for detecting anxiety: systematic review and meta-analysis[J]. J Med Internet Res, 2023, 25(8):e48754.[24]ANTONINI A, REICHMANN H, GENTILE G, et al. Toward objective monitoring of Parkinson’s disease motor symptoms using a wearable device: wearability and performance evaluation of PDMonitor[J]. Front Neurol, 2023, 14(16):e1080752. [25]PIET A, JABLONSKI L, DANIEL ONWUCHEKWA JI, et al. Non-invasive wearable devices for monitoring vital signs in patients with type 2 diabetes mellitus: a systematic review[J]. Bioengineering (Basel), 2023, 10(11):1321-1335.[26]BATSIS JA, ZAGARIA A, KOTZ DF, et al. Usability evaluation for the amulet wearable device in rural older adults with obesity[J]. Gerontechnology, 2018, 17(3):151-159.[27]CHEN W, KHURSHID S, SINGER DE, et al. Cost-effectiveness of screening for atrial fibrillation using wearable devices[J]. JAMA Health Forum, 2022,3(8):e222419.[28]ENGELGEER A, VAN WESTRHENEN A, THIJS RD, et al. An economic evaluation of the NightWatch for children with refractory epilepsy: insight into the cost-effectiveness and cost-utility[J]. Seizure, 2022, 101(1):156-161.[29]FEDERICI C, PECCHIA L. Early health technology assessment using the MAFEIP tool. A case study on a wearable device for fall prediction in elderly patients[J].Health and Technology, 2021,11(1):995-1002.[30]FLAUCHER M, ZAKREUSKAYA A, NISSEN M, et al. Evaluating the effectiveness of mobile health in breast cancer care: a systematic review[J]. Oncologist, 2023, 28(10):e847-e858.[31]REZVANI F, HEIDER D, HRTER M, et al. Telephone health coaching with exercise monitoring using wearable activity trackers (TeGeCoach) for improving walking impairment in peripheral artery disease: study protocol for a randomised controlled trial and economic evaluation[J]. BMJ Open, 2020, 10(6):e032146.[32]HA S, HO SH, BAE YH, et al. Digital health equity and tailored health care service for people with disability: user-centered design and usability study[J]. J Med Internet Res, 2023, 28(25):e50029.[33]RAN HH, URGESSA NA, GEETHAKUMARI P, et al. Detection and diagnostic accuracy of cardiac arrhythmias using wearable health devices: a systematic review[J]. Cureus, 2023, 15(12):e50952.[34]HEALY CA, CARRILLO RG. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: a cost-effectiveness evaluation[J]. Heart Rhythm, 2015, 12(7):1565-1573.[35]NICE. RespiraSense for continuously monitoring respiratory rate[EB/OL].(2022-07-05)[2024-01-23].https://www.nice.org.uk/advice/mib299.[36]NICE. Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis[EB/OL].(2017-01-18)[2024-01-23]. https://www.nice.org.uk/advice/mib93.[37]NICE. Zio XT for detecting cardiac arrhythmias[EB/OL]. (2020-11-01)[2024-01-23]. https://www.nice.org.uk/guidance/mtg52.[38]CADTH. At-home polysomnography versus in-clinic polysomnography for sleep disorders[EB/O]. (2023-07-27)[2024-01-23]. https://www.cadth.ca/home-polysomnography-versus-clinic-polysomnography-sleep-disorders.[39]CADTH. Hybrid closed-loop insulin delivery systems for people with type 1 diabetes[EB/OL]. (2021-07-31)[2024-01-23].https://www.cadth.ca/hybrid-closed-loop-insulin-delivery-systems-people-type-1-diabetes.[40]CADTH. Motorized walking devices for patients with compromised mobility: a review of clinical effectiveness, cost-effectiveness, and guidelines[EB/OL]. (2019-08-22)[2024-01-23]. https://www.cadth.ca/motorized-walking-devices-patients-compromised-mobility-review-clinical-effectiveness-cost.[41]CILLIERS L. Wearable devices in healthcare: privacy and information security issues[J]. Health Inf Manag, 2020, 49(2-3):150-156.[42]张彩霞,王向东.可穿戴医疗设备的安全方法研究[J].计算机科学,2016,43(6A):366-369.[43]XIONG H, ZHANG D,WANG L,et al. EEMC: Enabling energy-efficient mobile crowdsensing with anonymous participants[J]. ACM Transactions on Intelligent Systems and Technology (TIST),2015,6(3):1-26.[44]崔宏恩,姚绍卫.可穿戴医疗设备关键技术及其质量控制初探[J].中国医疗器械杂志,2015,39(2):113-117,121.[45]MEYER JT, GASSERT R, LAMBERCY O. An analysis of usability evaluation practices and contexts of use in wearable robotics[J]. Journal of NeuroEngineering and Rehabilitation, 2021, 18(1): 1-15.[46]CANALI S, SCHIAFFONATI V, ALIVERTI A. Challenges and recommendations for wearable devices in digital health: Data quality, interoperability, health equity, fairness[J]. PLOS Digit Health,2022,13(10):e0000104.[47]ZINZUWADIA A, SINGH JP. Wearable devices-addressing bias and inequity[J]. Lancet Digit Health, 2022, 4(12):e856-e857. [48]NICE. Evidence standards framework for digital health technologies[EB/OL].(2022-08-09)[2023-01-23].https://www.nice.org.uk/corporate/ecd7/chapter/how-to-meet-the-standards#standard-4-consider-health-and-care-inequalities-and-bias-mitigation.

相似文献/References:

[1]唐檬,陈英耀,茅艺伟,等.中国卫生技术评估决策转化现状及影响因素的定性研究[J].中国卫生质量管理,2015,22(06):95.
[2]王海银 张晓溪 房良 金春林.我国卫生技术评估流程规范研究[J].中国卫生质量管理,2016,23(06):60.[doi:10.13912/j.cnki.chqm.2016.23.6.21]
[3]魏巍 张涛 鱼敏.便携式早期清创冲洗器的卫生技术评估[J].中国卫生质量管理,2018,25(03):79.[doi:10.13912/j.cnki.chqm.2018.25.3.24]
[4]张曙欣 陈校云 冯力 宋杨杨 胡可慧 黄婉茹 裴治纲.澳大利亚和新西兰新兴卫生技术水平扫描网络的实践与启示[J].中国卫生质量管理,2019,26(02):106.[doi:10.13912/j.cnki.chqm.2019.26.2.31]
[5]孙辉 金春林 程文迪 房良 王海银.西班牙卫生技术评估的发展应用及启示[J].中国卫生质量管理,2019,26(03):106.[doi:10.13912/j.cnki.chqm.2019.26.3.29]
[6]王海银 丛郦萱 彭颖 王美凤 金春林.我国新医疗技术的定价及支付优化策略探讨[J].中国卫生质量管理,2020,27(01):105.[doi:10.13912/j.cnki.chqm.2020.27.1.27]
[7]程文迪 孙辉 房良 王海银.泰国卫生技术评估机制建设现状及启示[J].中国卫生质量管理,2020,27(01):109.[doi:10.13912/j.cnki.chqm.2020.27.1.28]
[8]邱英鹏赵翔肖月赵羽西.高值医用耗材定义与治理内涵研究[J].中国卫生质量管理,2021,28(05):1.[doi:10.13912/j.cnki.chqm.2021.28.5.01 ]
 QIU Yingpeng,ZHAO Xiang,XIAO Yue.The Definition and Governance Connotation of High Value Medical Consumables[J].Chinese Health Quality Management,2021,28(10):1.[doi:10.13912/j.cnki.chqm.2021.28.5.01 ]
[9]赵羽西邱英鹏肖月.英国高值医用耗材准入及招采管理经验分享:以英格兰为例[J].中国卫生质量管理,2021,28(05):8.[doi:10.13912/j.cnki.chqm.2021.28.5.03 ]
 ZHAO Yuxi,QIU Yingpeng,XIAO Yue.Access and Procurement Management of High Value Medical Consumables in the UK: A Case Study of England[J].Chinese Health Quality Management,2021,28(10):8.[doi:10.13912/j.cnki.chqm.2021.28.5.03 ]
[10]邱英鹏赵羽西赵翔肖月.澳大利亚假体类高值医用耗材医保准入管理经验及启示[J].中国卫生质量管理,2021,28(05):12.[doi:10.13912/j.cnki.chqm.2021.28.5.04 ]
 QIU Yingpeng,ZHAO Yuxi,ZHAO Xiang.Experience in Medical Insurance Access Management of Prosthetic High Value Medical Consumables in Australia and Its Implications[J].Chinese Health Quality Management,2021,28(10):12.[doi:10.13912/j.cnki.chqm.2021.28.5.04 ]

更新日期/Last Update: 2024-10-15
版权所有© 2015 《中国卫生质量管理》杂志编辑部
陕ICP备20003462号-1
地 址:西安市友谊西路256号; 邮编:710068 ;电话:029-85214975(传真) 029-85253261转2494
技术支持:西安三才科技实业有限公司 029-88222991